Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy

被引：0
|
作者：
Kei Fukami
Sho-ichi Yamagishi
Melinda T Coughlan
Brooke E Harcourt
Phillip Kantharidis
Vicki Thallas-Bonke
Seiya Okuda
Mark E Cooper
Josephine M Forbes
机构：
[1] Kurume University School of Medicine,Division of Nephrology, Department of Medicine
[2] Kurume University School of Medicine,Department of Pathophysiology and Therapeutics of Diabetic Vascular Complications
[3] Baker IDI Heart and Diabetes Institute,Diabetes Division
[4] Monash University,Department of Medicine, Central Clinical School
[5] Mater Medical Research Institute,Department of Glycation and Diabetic Complications
来源：
Diabetology & Metabolic Syndrome | / 6卷
关键词：
Advanced glycation end products; Diabetic nephropathy; Renin-angiotensin system; MMP-2; RAGE; NF-κB;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Ramipril inhibits AGE-RAGE-induced matrix metalloproteinase-2 activation in experimental diabetic nephropathy
    Fukami, Kei
    Yamagishi, Sho-ichi
    Coughlan, Melinda T
    Harcourt, Brooke E
    Kantharidis, Phillip
    Thallas-Bonke, Vicki
    Okuda, Seiya
    Cooper, Mark E
    Forbes, Josephine M
    DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [2] Matrix metalloproteinase-2 and mesangiolysis in diabetic nephropathy
    Kanauchi, M
    Nishioka, H
    Kawano, T
    Uyama, H
    Shiiki, H
    Dohi, K
    NEPHRON, 1999, 83 (02): : 174 - 175
  • [3] Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice
    Takamiya, Yoshimi
    Fukami, Kei
    Yamagishi, Sho-ichi
    Kaida, Yusuke
    Nakayama, Yosuke
    Obara, Nana
    Iwatani, Ryuji
    Ando, Ryotaro
    Koike, Kiyomi
    Matsui, Takanori
    Nishino, Yuri
    Ueda, Seiji
    Cooper, Mark E.
    Okuda, Seiya
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 (01) : 55 - 62
  • [4] An imbalance between matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 contributes to the development of early diabetic nephropathy
    Han, Sang Youb
    Jee, Yi Hwa
    Han, Kum Hyun
    Kang, Young Sun
    Kim, Hyoung Kyu
    Han, Jee Young
    Kim, Young Sik
    Cha, Dae Ryong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 (09) : 2406 - 2416
  • [5] Enhanced expression of two discrete isoforms of matrix metalloproteinase-2 in experimental and human diabetic nephropathy
    Kim, Sang Soo
    Shin, Nari
    Bae, Sun Sik
    Lee, Min Young
    Rhee, Harin
    Kim, Il Young
    Seong, Eun Young
    Lee, Dong Won
    Lee, Soo Bong
    Kwak, Ihm Soo
    Lovett, David H.
    Song, Sang Heon
    PLOS ONE, 2017, 12 (02):
  • [6] Association of matrix metalloproteinase-2 gene variants with diabetic nephropathy risk
    Sarray, Sameh
    Lamine, Laila Ben
    Dallel, Meriem
    Ezzidi, Intissar
    Sellami, Nejla
    Turki, Amira
    Moustafa, Amgad Elbaz El-Agroudy
    Mtiraoui, Nabil
    JOURNAL OF GENE MEDICINE, 2023, 25 (11):
  • [7] Production and activation of matrix metalloproteinase-2 in proliferative diabetic retinopathy
    Noda, K
    Ishida, S
    Inoue, M
    Obata, K
    Oguchi, Y
    Okada, Y
    Ikeda, E
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 (05) : 2163 - 2170
  • [8] Kallistatin protects against diabetic nephropathy in db/db mice by suppressing AGE-RAGE-induced oxidative stress
    Yiu, Wai Han
    Wong, Dickson W. L.
    Wu, Hao Jia
    Li, Rui Xi
    Yam, Irene
    Chan, Loretta Y. Y.
    Leung, Joseph C. K.
    Lan, Hui Yao
    Lai, Kar Neng
    Tang, Sydney C. W.
    KIDNEY INTERNATIONAL, 2016, 89 (02) : 386 - 398
  • [9] Carvedilol Inhibits Matrix Metalloproteinase-2 Activation in Experimental Autoimmune Myocarditis: Possibilities of Cardioprotective Application
    Skrzypiec-Spring, Monika
    Haczkiewicz, Katarzyna
    Sapa, Agnieszka
    Piasecki, Tomasz
    Kwiatkowska, Joanna
    Ceremuga, Ireneusz
    Wozniak, Mieczyslaw
    Biczysko, Wieslawa
    Kobierzycki, Christopher
    Dziegiel, Piotr
    Podhorska-Okolow, Marzenna
    Szelag, Adam
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS, 2018, 23 (01) : 89 - 97
  • [10] Urine matrix metalloproteinase-2,-8 and-9 activities in type 2 diabetic nephropathy
    van der Zijl, N. J.
    Hanemaaijer, R.
    Tushuizen, M. E.
    Schindhelm, R. K.
    Boerop, J.
    Rustemeijer, C.
    Bilo, H. J.
    Verheijen, J. H.
    Diamant, M.
    DIABETOLOGIA, 2008, 51 : S486 - S487
12345